Correlation Between Corvus Pharmaceuticals and Paratek Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Corvus Pharmaceuticals and Paratek Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Corvus Pharmaceuticals and Paratek Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Corvus Pharmaceuticals and Paratek Pharmaceuticals, you can compare the effects of market volatilities on Corvus Pharmaceuticals and Paratek Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Corvus Pharmaceuticals with a short position of Paratek Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Corvus Pharmaceuticals and Paratek Pharmaceuticals.
Diversification Opportunities for Corvus Pharmaceuticals and Paratek Pharmaceuticals
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Corvus and Paratek is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Corvus Pharmaceuticals and Paratek Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Paratek Pharmaceuticals and Corvus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Corvus Pharmaceuticals are associated (or correlated) with Paratek Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Paratek Pharmaceuticals has no effect on the direction of Corvus Pharmaceuticals i.e., Corvus Pharmaceuticals and Paratek Pharmaceuticals go up and down completely randomly.
Pair Corralation between Corvus Pharmaceuticals and Paratek Pharmaceuticals
Given the investment horizon of 90 days Corvus Pharmaceuticals is expected to generate 0.97 times more return on investment than Paratek Pharmaceuticals. However, Corvus Pharmaceuticals is 1.03 times less risky than Paratek Pharmaceuticals. It trades about 0.1 of its potential returns per unit of risk. Paratek Pharmaceuticals is currently generating about 0.04 per unit of risk. If you would invest 100.00 in Corvus Pharmaceuticals on August 31, 2024 and sell it today you would earn a total of 842.00 from holding Corvus Pharmaceuticals or generate 842.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 31.11% |
| Values | Daily Returns |
Corvus Pharmaceuticals vs. Paratek Pharmaceuticals
Performance |
| Timeline |
| Corvus Pharmaceuticals |
| Paratek Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Corvus Pharmaceuticals and Paratek Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Corvus Pharmaceuticals and Paratek Pharmaceuticals
The main advantage of trading using opposite Corvus Pharmaceuticals and Paratek Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Corvus Pharmaceuticals position performs unexpectedly, Paratek Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Paratek Pharmaceuticals will offset losses from the drop in Paratek Pharmaceuticals' long position.| Corvus Pharmaceuticals vs. Mereo BioPharma Group | Corvus Pharmaceuticals vs. Terns Pharmaceuticals | Corvus Pharmaceuticals vs. PDS Biotechnology Corp | Corvus Pharmaceuticals vs. Inozyme Pharma |
| Paratek Pharmaceuticals vs. Corvus Pharmaceuticals | Paratek Pharmaceuticals vs. Immutep Ltd ADR | Paratek Pharmaceuticals vs. Lyra Therapeutics | Paratek Pharmaceuticals vs. Equillium |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |